Brind.

BioPharma and OncoX BioPharma signed a strategic licensing agreement for oncology development.

1 report, 1 independent Updated Jul 24

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

BioPharma

Keep exploring

The entities involved

BioPharma
company in Jílové u Prahy, Czech Republic
- BioPharma stock was traded on the NASDAQ stock exchange on July 30, 2026, with its performance tracked by financial blogs.Mon 02:47
- BioPharma and Milestone Pharmaceuticals are small-cap healthcare companies.Wed 08:33

Coverage

Newest first; wire copies grouped

Jul 24NewMediaWireABVC BioPharma Strengthens Oncology Partnership With $100,000 Milestone Payment From OncoX BioPharma Total licensing revenue crosses $1.046 million; strategic collaboration with OncoX evolves toward